Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

January 2022: Dr. Sameer Parikh on COVID-19 State of Affairs for Those with CLL/SLL

This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.

In the first half of January 2022, Dr. Sameer Parikh from Mayo, Rochester, MN, discusses the present state of affairs related to COVID-19 for those with chronic lymphocytic leukemia/small lymphocytic lymphoma or CLL/SLL.

In this short monologue, he touches on:

  • the Omicron surge
  • lack of response to vaccines in many with CLL/SLL
  • the need to continue to follow precautions such as masking and social distancing, even if vaccinated
  • waiting for the recently authorized Evusheld, the long-acting antibody preventative, to be more available
  • the reality that all CLL/SLL patients, regardless of their treatment status, are immunocompromised

It can be hard not to be discouraged, but there is a reason for hope.  This surge could pass quickly.  There are already very effective medications authorized or approved as described in the CDC HEALTH ADVISORY: Using Therapeutics to Prevent and Treat COVID-19 for the immunocompromised, and that they won’t always be in short supply.

Stay strong.  We are all in this together.

Brian

Brian Koffman MDCM (retired) MS Ed (he, him, his)
Co-Founder, Executive VP, and Chief Medical Officer
CLL Society, Inc.

RECENT NEWS

When appropriate, the CLL Society will be posting updates and background information on the present Coronavirus pandemic focusing on reliable primary sources of information and avoiding most of the news that is not directly from reliable medical experts or government and world health agencies.